These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 7547637)
1. Genomic DNA and messenger RNA expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines. Zhou X; Suzuki H; Shimada Y; Imamura M; Yin J; Jiang HY; Tarmin L; Abraham JM; Meltzer SJ Genes Chromosomes Cancer; 1995 Aug; 13(4):285-90. PubMed ID: 7547637 [TBL] [Abstract][Full Text] [Related]
2. Intragenic mutations of CDKN2B and CDKN2A in primary human esophageal cancers. Suzuki H; Zhou X; Yin J; Lei J; Jiang HY; Suzuki Y; Chan T; Hannon GJ; Mergner WJ; Abraham JM Hum Mol Genet; 1995 Oct; 4(10):1883-7. PubMed ID: 8595411 [TBL] [Abstract][Full Text] [Related]
3. The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes. Stadler WM; Olopade OI Urol Res; 1996; 24(4):239-44. PubMed ID: 8873383 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors. Ichikawa Y; Yoshida S; Koyama Y; Hirai M; Ishikawa T; Nishida M; Tsunoda H; Kubo T; Miwa M; Uchida K Int J Cancer; 1996 Dec; 69(6):466-70. PubMed ID: 8980248 [TBL] [Abstract][Full Text] [Related]
6. Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan. Lin YW; Chen CH; Huang GT; Lee PH; Wang JT; Chen DS; Lu FJ; Sheu JC Eur J Cancer; 1998 Oct; 34(11):1789-95. PubMed ID: 9893670 [TBL] [Abstract][Full Text] [Related]
7. Association of CDKN2A(p16)/CDKN2B(p15) alterations and homozygous chromosome arm 9p deletions in human lung carcinoma. Hamada K; Kohno T; Kawanishi M; Ohwada S; Yokota J Genes Chromosomes Cancer; 1998 Jul; 22(3):232-40. PubMed ID: 9624535 [TBL] [Abstract][Full Text] [Related]
8. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Sonoda Y; Yoshimoto T; Sekiya T Oncogene; 1995 Nov; 11(10):2145-9. PubMed ID: 7478535 [TBL] [Abstract][Full Text] [Related]
9. Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Gonzalez-Zulueta M; Bender CM; Yang AS; Nguyen T; Beart RW; Van Tornout JM; Jones PA Cancer Res; 1995 Oct; 55(20):4531-5. PubMed ID: 7553622 [TBL] [Abstract][Full Text] [Related]
10. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related]
11. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers. Yoshida S; Todoroki T; Ichikawa Y; Hanai S; Suzuki H; Hori M; Fukao K; Miwa M; Uchida K Cancer Res; 1995 Jul; 55(13):2756-60. PubMed ID: 7796400 [TBL] [Abstract][Full Text] [Related]
12. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. Kelley MJ; Nakagawa K; Steinberg SM; Mulshine JL; Kamb A; Johnson BE J Natl Cancer Inst; 1995 May; 87(10):756-61. PubMed ID: 7563154 [TBL] [Abstract][Full Text] [Related]
13. MTS1/p16/CDKN2 lesions in primary glioblastoma multiforme. Moulton T; Samara G; Chung WY; Yuan L; Desai R; Sisti M; Bruce J; Tycko B Am J Pathol; 1995 Mar; 146(3):613-9. PubMed ID: 7887443 [TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of P16(Ink4)/CDKN2 and P15(INK4B)/MTS2 genes in primary human testicular germ cell tumors. Heidenreich A; Gaddipati JP; Moul JW; Srivastava S J Urol; 1998 May; 159(5):1725-30. PubMed ID: 9554401 [TBL] [Abstract][Full Text] [Related]
15. The multiple tumor suppressor 1/cyclin-dependent kinase inhibitor 2 gene in human central nervous system primitive neuroectodermal tumor. Raffel C; Ueki K; Harsh GR; Louis DN Neurosurgery; 1995 May; 36(5):971-4; discussion 974-5. PubMed ID: 7791990 [TBL] [Abstract][Full Text] [Related]
16. [Loss of CDKN2 gene and amplification of cyclin D1 gene in human esophageal cancer]. Zheng J; Hou P; Zhou C Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):408-11. PubMed ID: 9387288 [TBL] [Abstract][Full Text] [Related]
17. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma. Maesawa C; Tamura G; Nishizuka S; Ogasawara S; Ishida K; Terashima M; Sakata K; Sato N; Saito K; Satodate R Cancer Res; 1996 Sep; 56(17):3875-8. PubMed ID: 8752149 [TBL] [Abstract][Full Text] [Related]
18. Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas. Tahara H; Smith AP; Gaz RD; Arnold A J Clin Endocrinol Metab; 1996 Oct; 81(10):3663-7. PubMed ID: 8855819 [TBL] [Abstract][Full Text] [Related]
19. Homozygous deletions at chromosome 9p21 and mutation analysis of p16 and p15 in microdissected primary non-small cell lung cancers. Packenham JP; Taylor JA; White CM; Anna CH; Barrett JC; Devereux TR Clin Cancer Res; 1995 Jul; 1(7):687-90. PubMed ID: 9816033 [TBL] [Abstract][Full Text] [Related]
20. Alterations of CDKN2 (p16) in non-small cell lung cancer. de Vos S; Miller CW; Takeuchi S; Gombart AF; Cho SK; Koeffler HP Genes Chromosomes Cancer; 1995 Nov; 14(3):164-70. PubMed ID: 8589032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]